Can ammonia levels be elevated in hemodialysis patients?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 10, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can Ammonia Levels Be Elevated in Hemodialysis Patients?

Yes, ammonia levels can paradoxically rise during hemodialysis in a significant proportion of patients, occurring in approximately 43% of hemodialysis patients despite effective urea removal. 1

Understanding the Paradox

While hemodialysis effectively removes urea and is used therapeutically to treat severe hyperammonemia, the dialysis procedure itself can cause a modest but significant rise in blood ammonia levels in certain patients. This counterintuitive finding contrasts with the well-documented reduction in breath ammonia following hemodialysis.

Key Mechanisms

The rise in blood ammonia during hemodialysis correlates with:

  • Bicarbonate changes: Strong correlation (r = 0.61, P < 0.01) between rising blood ammonia and increasing serum bicarbonate levels 1
  • Hemodynamic instability: In patients who develop elevated ammonia, there is a strong correlation with drops in mean arterial pressure (r = 0.88, P < 0.01) 1
  • Intradialytic hypotension: Patients with rising ammonia tend to have lower nadir systolic blood pressures during dialysis (124 ± 8 vs. 136 ± 6 mmHg) 1

Baseline Ammonia Levels

Importantly, baseline blood ammonia levels in hemodialysis patients (before dialysis) are not significantly different from healthy controls or peritoneal dialysis patients. 1 This means chronic kidney disease itself does not inherently cause hyperammonemia, but the dialysis procedure can trigger it.

Clinical Implications

When to Monitor

Monitor ammonia levels in hemodialysis patients who develop:

  • Altered mental status during or after dialysis
  • Unexplained encephalopathy
  • Intradialytic hypotension
  • Significant bicarbonate shifts

Special Populations at Risk

Hemodialysis patients with underlying metabolic disorders (such as adult-onset type II citrullinemia) can develop severe hyperammonemia requiring intensified dialysis strategies. In documented cases, increasing dialysis frequency to four 5-hour sessions per week successfully reversed both clinical manifestations and brain MRI abnormalities. 2

Therapeutic Considerations

When hemodialysis is used to treat hyperammonemia (not cause it), ammonia clearance is highly effective:

  • Ammonia extraction can exceed 80% with optimized dialysate flow rates 3
  • Clearance is blood flow-dependent and influenced by dialysate flow rate and dialyzer surface 3
  • Plasma ammonia can decline by 56% within 90 minutes of treatment 4

Dialysis Modality Selection

For treating severe hyperammonemia:

  • High-dose continuous venovenous hemodialysis (CVVHD) is recommended as first-line when hemodynamic stability allows 5
  • Intermittent hemodialysis provides faster ammonia reduction (50% reduction in 1-2 hours) but carries higher risk of rebound hyperammonemia 5
  • Dual dialysis approach (combining intermittent HD with CVVHD) can be effective in critically ill patients 6

Common Pitfalls

  1. Assuming dialysis always lowers ammonia: Nearly half of patients may experience paradoxical rises
  2. Overlooking hemodynamic factors: Intradialytic hypotension may trigger ammonia elevation
  3. Missing metabolic disorders: Underlying urea cycle defects can be unmasked or worsened by standard hemodialysis
  4. Inadequate monitoring: Ammonia levels should be checked if neurological symptoms develop during or after dialysis

The relationship between hemodialysis and ammonia is bidirectional: while dialysis effectively treats hyperammonemia when used therapeutically, the procedure itself can paradoxically elevate ammonia levels in a substantial minority of patients, particularly those experiencing hemodynamic instability or significant acid-base shifts.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.